[1]
2026. PROFILE OF INTRANASAL CORTICOSTEROIDS IN ITALY: SAFETY, COST/EFFECTIVENESS, LOCAL AND SYSTEMIC ADVERSE EFFECTS. EuroMediterranean Biomedical Journal. 9, (Jan. 2026). DOI:https://doi.org/10.3269/1970-5492.2014.9.11.